Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.
2.

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.

Greenfeld H, Takasaki K, Walsh MJ, Ersing I, Bernhardt K, Ma Y, Fu B, Ashbaugh CW, Cabo J, Mollo SB, Zhou H, Li S, Gewurz BE.

PLoS Pathog. 2015 May 21;11(5):e1004890. doi: 10.1371/journal.ppat.1004890. eCollection 2015 May.

3.

Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signaling.

Shimabuku T, Tamanaha A, Kitamura B, Tanabe Y, Tawata N, Ikehara F, Arakaki K, Kinjo T.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):1920-34. eCollection 2014.

4.

Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1.

Nacken W, Anhlan D, Hrincius ER, Mostafa A, Wolff T, Sadewasser A, Pleschka S, Ehrhardt C, Ludwig S.

J Virol. 2014 Aug;88(16):8843-52. doi: 10.1128/JVI.00424-14. Epub 2014 May 28.

5.

Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.

Siouda M, Frecha C, Accardi R, Yue J, Cuenin C, Gruffat H, Manet E, Herceg Z, Sylla BS, Tommasino M.

PLoS Pathog. 2014 May 8;10(5):e1004125. doi: 10.1371/journal.ppat.1004125. eCollection 2014 May.

6.

Modulation of autophagy-like processes by tumor viruses.

Mack HI, Munger K.

Cells. 2012 Jun 25;1(3):204-47. doi: 10.3390/cells1030204.

7.

Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α.

Accardi R, Fathallah I, Gruffat H, Mariggiò G, Le Calvez-Kelm F, Voegele C, Bartosch B, Hernandez-Vargas H, McKay J, Sylla BS, Manet E, Tommasino M.

PLoS Pathog. 2013 Mar;9(3):e1003186. doi: 10.1371/journal.ppat.1003186. Epub 2013 Mar 14.

8.

Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

Saito S, Murata T, Kanda T, Isomura H, Narita Y, Sugimoto A, Kawashima D, Tsurumi T.

J Virol. 2013 Apr;87(7):4060-70. doi: 10.1128/JVI.02020-12. Epub 2013 Jan 30.

9.

Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.

Hatton O, Lambert SL, Krams SM, Martinez OM.

PLoS One. 2012;7(8):e42610. doi: 10.1371/journal.pone.0042610. Epub 2012 Aug 3.

10.

c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells.

Tudor CS, Dawson CW, Eckhardt J, Niedobitek G, Büttner AC, Seliger B, Hartmann A, Buettner M.

Br J Cancer. 2012 Jun 5;106(12):1980-8. doi: 10.1038/bjc.2012.197. Epub 2012 May 15.

11.

Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder.

Hatton O, Martinez OM, Esquivel CO.

Pediatr Transplant. 2012 May;16(3):220-9. doi: 10.1111/j.1399-3046.2012.01656.x. Epub 2012 Feb 21. Review.

12.

Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.

Sides MD, Block GJ, Chadwick RW, Shan B, Flemington EK, Lasky JA.

Virol J. 2011 Oct 5;8:461. doi: 10.1186/1743-422X-8-461.

13.

Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.

Cesarman E.

Cancer Lett. 2011 Jun 28;305(2):163-74. doi: 10.1016/j.canlet.2011.03.003. Epub 2011 Apr 13. Review.

14.

Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta.

Kung CP, Meckes DG Jr, Raab-Traub N.

J Virol. 2011 May;85(9):4399-408. doi: 10.1128/JVI.01703-10. Epub 2011 Feb 9.

16.

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.

Song YJ, Izumi KM, Shinners NP, Gewurz BE, Kieff E.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18448-53. doi: 10.1073/pnas.0809933105. Epub 2008 Nov 18.

17.

The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation.

Li L, Soetandyo N, Wang Q, Ye Y.

Biochim Biophys Acta. 2009 Feb;1793(2):346-53. doi: 10.1016/j.bbamcr.2008.09.013. Epub 2008 Oct 8.

18.

Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.

Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M.

Nucleic Acids Res. 2008 Nov;36(20):6608-19. doi: 10.1093/nar/gkn666. Epub 2008 Oct 21.

19.

Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells.

Chen YR, Liu MT, Chang YT, Wu CC, Hu CY, Chen JY.

J Virol. 2008 Aug;82(16):8124-37. doi: 10.1128/JVI.00430-08. Epub 2008 Jun 4.

20.

Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling.

Li L, Hailey DW, Soetandyo N, Li W, Lippincott-Schwartz J, Shu HB, Ye Y.

Biochim Biophys Acta. 2008 Jun;1783(6):1140-9. doi: 10.1016/j.bbamcr.2008.01.029. Epub 2008 Feb 19.

Items per page

Supplemental Content

Write to the Help Desk